APPEND-CT Registry
APPEND-CT
Cardiac Computed Tomography Following Watchman FLX Left Atrial APPENDage Closure
1 other identifier
observational
2,000
2 countries
2
Brief Summary
The APPEND-CT registry is an investigator-driven multicenter retrospective observational database intended to compile cardiac CT follow-up data after Watchman FLX device implantation and function as a platform for answering clinical and research questions within LAAC follow-up. The derived studies should support therapeutic decision-making, improve risk-stratification in LAAC and help generate hypotheses for potential future clinical intervention trials.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2024
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2024
CompletedFirst Posted
Study publicly available on registry
January 19, 2024
CompletedStudy Start
First participant enrolled
February 14, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedMay 30, 2024
May 1, 2024
6 months
January 9, 2024
May 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ischemic stroke
Clinically affirmed ischemic stroke
Minimum 12 months
Secondary Outcomes (3)
Device-related thrombosis
Minimum 12 months
Major bleeding
Minimum 12 months
All-cause and cardiovascular mortality
Minimum 12 months
Interventions
Early (30-120 days) CT follow-up after Watchman FLX LAAO
Eligibility Criteria
Watchman FLX implanted patients with a minimum of one early follow-up cardiac CT.
You may qualify if:
- Watchman FLX LAAO
- A minimum of one follow-up cardiac CT performed within 30-120 days post-procedure.
- A minimum of one year clinical follow-up data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aarhus University Hospitallead
- Mayo Cliniccollaborator
- Boston Scientific Corporationcollaborator
Study Sites (2)
Mayo Clinic
Rochester, Minnesota, 55901, United States
Aarhus University Hospital
Aarhus, 8200, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anders Kramer, MD
Aarhus University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD-fellow
Study Record Dates
First Submitted
January 9, 2024
First Posted
January 19, 2024
Study Start
February 14, 2024
Primary Completion
August 1, 2024
Study Completion
January 1, 2025
Last Updated
May 30, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share
Patient data will be registered under a pseudonymous registry-ID and will not be personally identifiable.